MoneyWorks4Me

Glenmark Pharmaceuticals informs about board meeting

19 Jan 2026 Evaluate
Glenmark Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 to consider and approve the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2025.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..